May 15 (Reuters) -
TAISHO PHARMACEUTICAL CO LTD
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to Six months to
Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 198.86 201.67 199.50 99.00
(-1.4 pct) (+3.8 pct) (+0.3%) (-0.5%)
Operating 32.01 34.21 29.50 14.50
(-6.4 pct) (+59.1 pct) (-7.8%) (-18.0%)
Recurring 38.98 40.12 36.50 18.50
(-2.8 pct) (+45.8 pct) (-6.4%) (-12.3%)
Net 11.86 25.91 23.50 12.00
(-54.2 pct) (+54.7 pct) (+98.1%)
EPS Y40.36 Y86.99 Y81.16 Y41.45
Annual div Y27.00 Y27.00 Y27.00
-Q2 div Y12.00 Y12.00 Y12.00
-Q4 div Y15.00 Y15.00 Y15.00
NOTE - Taisho Pharmaceutical Co Ltd is a top-ranked maker of non-prescription drugs.
If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.
For latest earnings estimates made by Toyo Keizai, please
double click on 4535.TK1.
